Please login to the form below

Not currently logged in
Email:
Password:

pitavastatin

This page shows the latest pitavastatin news and features for those working in and with pharma, biotech and healthcare.

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma

The Italian firm has already launched its own oral treatment for disorders of lipoprotein metabolism, Livazo (pitavastatin), on the Swiss market, having been approved for use in adults by the European

Latest news

  • FDA strengthens safety warnings for Lipitor, Crestor, Zocor

    Others statins to be affected by label updates are Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin) and Pravachol (pravastatin).

  • Recordati boosted by new launches and Turkish pharma acquisition

    The initial launch in Spain and Portugal of Livazo (pitavastatin), a statin indicated for the reduction of elevated levels of cholesterol, also helped add to the company's sales figures.

  • Label change for Lilly's Livalo

    The US Food and Drug Administration (FDA) has said Eli Lilly &Company can update the label of cholesterol drug Livalo (pitavastatin) to remove a warning against the use of the drug

  • Thin on the ground

    Pitavastatin. Livalo (Kowa Pharmaceuticals America, Eli Lilly). Primary hyperlipidaemia or mixed dyslipidaemia.

  • Pharma news in brief

    The Swiss firm said it decided to stop the development of NKS104 (pitavastatin), a lipid lowering statin, as ìdata from recent investigational trials showed the compound was no longer competitive enoughî.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Country report: The healthcare market in Germany Country report: The healthcare market in Germany

    Out of the 10 products assessed last year, four have obtained poor innovation scores: Esbriet (pirfenidone), Livazo (pitavastatin), Yellox (bromfenac) and Trajenta (linagliptin) and a majority of manufacturers have struggled – sometimes

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics